N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo

This publication has 21 references indexed in Scilit:

• Treatment of Gaucher disease with an enzyme inhibitor
  Glycoconjugate Journal, 1996
• TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASE
  Transplantation, 1995
• Gene theraphy of lysosomal storage disorders
  British Medical Bulletin, 1995
• Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources
  Annals of Internal Medicine, 1995
• Inhibitors of Glycosphingolipid Biosynthesis.
  Trends in Glycoscience and Glycotechnology, 1995
• Gaucher disease as a paradigm of current issues regarding single gene mutations of humans.
  Proceedings of the National Academy of Sciences, 1993
• Gaucher disease: new molecular approaches to diagnosis and treatment
  Science, 1992
• LYSOSOMAL STORAGE DISEASES
  Annual Review of Biochemistry, 1991
• Clinical and Biochemical Outcome of Marrow Transplantation for Gaucher Disease of the Norrbottnian Type
  Acta Paediatrica, 1990
• Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
  Proceedings of the National Academy of Sciences, 1990